Dr Reddy’s Q1: warning letter ‘significantly impacted our earnings’
US FDA warnings and Venezuela's economic crisis have contributed to “a challenging quarter” for Dr Reddy’s, with its API business being particularly affected.
Archives for July 27, 2016
Cambrex predicts flat generic API sales for 2016
Cambrex to start work on Pharma 4 API site in 2016
Cambrex has said it will invest around $20m in its Pharma 4 API facility before the end of the year in an effort to get ahead of the capacity utilisation curve.
Survey: nearly two thirds of respondents now use CROs
As part of a recent survey, 62% of respondents said they are more likely to engage a clinical research organization (CRO) partner for clinical research than they were five years ago.
Scientists at ex AstraZeneca site join Obama’s $350m antibiotic effort
Scientists at AstraZeneca’s former R&D site in Alderley Park will play a key role in researching antibiotics and the spread of resistance under an initiative launched by US President Barack Obama.
Amgen begins to see results from manufacturing efficiency drive
A restructuring programme which closed two US facilities and slashed hundreds of jobs has paid off says Amgen, attributing increased margins to better manufacturing efficiencies.